Srikanth Venkatraman
Private Equity Investor at Disc Medicine Opco, Inc.
Profile
Srikanth Venkatraman is currently a Senior Vice President at Disc Medicine Opco, Inc. He was previously a Director & Principal Scientist at Merck & Co., Inc. from 2012 to 2016.
He also served as an Advisor at Atlas Venture Advisors, Inc. Dr. Venkatraman holds a doctorate degree from the University of Pittsburgh and the University of Illinois At Urbana–Champaign, and a graduate degree from the Indian Institute of Technology Madras.
Srikanth Venkatraman active positions
Companies | Position | Start |
---|---|---|
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Private Equity Investor | 31/12/2016 |
Former positions of Srikanth Venkatraman
Companies | Position | End |
---|---|---|
MERCK & CO., INC. | Private Equity Investor | 31/10/2016 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Training of Srikanth Venkatraman
University of Pittsburgh | Doctorate Degree |
Indian Institute of Technology Madras | Graduate Degree |
University of Illinois At Urbana–Champaign | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
MERCK & CO., INC. | Health Technology |
Private companies | 2 |
---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. BiotechnologyHealth Technology Disc Medicine, Inc. engages in the development of therapies addressing ineffective red blood cell production in hematologic diseases. Its product pipeline includes anti-hemojuvelin antibody and Matriptase-2 inhibitor. The company was founded by Brian MacDonald and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Srikanth Venkatraman